AlphAIAlphAI — Financial news for AI agents
gurufocus.comOCT 212 min read$CME

Is CME Group Inc (CME) Overvalued After Beating Q3 Earnings Esti

CME Group Inc (CME) reported Q3 2026 revenue of $1.7 billion, net income of $1 billion, and EPS of $2.89, exceeding analyst estimates. The company saw record trading volumes and growth across asset classes. GuruFocus values CME at $275.77, suggesting a 7.1% overvaluation at the current price of $295.31. Insider activity shows more shares sold than bought.

Original reporting
gurufocus.com
Published Oct 21, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The earnings beat and record revenue reinforce CME's market leadership, but valuation concerns and insider sales add caution.

02

Market read

Strong earnings could drive short‑term buying in CME and related financial stocks.

03

What to watch

Insider selling and potential regulatory headwinds could temper gains.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

CME Group filed an 8‑K on Oct 21, 2026, detailing its Q3 results and valuation metrics.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 2026 earnings beating estimates with record revenue and net income.

Expected impact

likely upward pressure as investors price in stronger-than-expected results

Evidence & confidence

Revenue and EPS both exceeded forecasts, indicating robust demand for CME's derivatives services.

Market effects

Sector

Positive earnings may lift broader financial services and exchange sector sentiment.

Regional

U.S. markets may see a modest lift in financial stocks.

Global

CME's global derivatives footprint could boost global risk‑management demand.

Counterpoint

What could challenge this read

Valuation appears stretched; overvaluation risk may limit upside.

Key entities

  • company
    CME Group Inc

    Operator of the world's largest derivatives marketplace.

Read at source← All news

StoryCME Group posts record Q3 revenue and adjusted EPS beat, but shares dip on guidance concerns

Also covered by

6 outlets

Related articles

OCT 21
$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

marketscreener.com3 min
OCT 21
$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

marketscreener.com2 min
OCT 21
$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.

gurufocus.com2 min